Jim Golden, formerly director of bioinformatics at New Haven, Conn.-based CuraGen, has moved on to serve as business development manager at the company’s technology spin-off, 454 Corp.
454, under wraps since its launch on June 2000, “will come out of stealth mode soon,” said Golden.
Myra Williams, former CIO for Glaxo and former president and CEO of Molecular Applications Group, has joined the scientific advisory board of cheminformatics company Synthematix. The company, based in Research Triangle Park, NC, also appointed Tom Cori, former chairman and CEO of Sigma-Aldrich, to its SAB.